Sai Life Sciences and AstraZeneca have published a study titled “ReactIR Monitoring of Turbo-Hauser Base Formation Enables a Robust Iodination […]
Sai Life Sciences Earns Great Place To Work® Certification for the Second Time
30 Oct 2026
Hyderabad, October 19, 2026: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE) has once again earned the Great Place To Work® certification for 2026–27. This marks the company's second certification and reflects employee feedback on their workplace experiences and the culture being built across the organization.
The employee feedback highlighted Pride, Credibility and Competency of Management as some of the company's strongest areas. These results reflect the pride employees feel in being part of Sai Life Sciences, the trust they place in the organization and their confidence in its leadership.
Over the past year, the company has continued to invest in learning and career development, employee wellbeing and inclusion, and recognition and meaningful employee experiences. These efforts reflect its commitment to creating a workplace where people can do their best work and build fulfilling careers.
The certification reinforces Sai Life Sciences' commitment to listening to its employees, learning from their feedback and continually improving the workplace experience as the organization grows.
Related News
As drug discovery programs increasingly demand faster optimization cycles and access to broader chemical space, advanced chemistry approaches are moving […]
20 May 2026
EBITDA up by 56%YoY; Net Profit up by 109%YoY Hyderabad, May 14, 2026: Sai Life Sciences Limited (BSE: 544306 I NSE: […]